| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.002 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |